什麼是 SEC Form 13F 申報?美股機構大戶持股全攻略
完整解讀 Form 13F 申報規範、1 億美元門檻與 45 天延遲申報機制,學會如何追蹤頂級對沖基金與機構法人持倉動向。
CIK: 0001920938
申報總市值
US$27.0億
US$27.0億
73 檔
36.8%
在 Q3 2025 申報期間,Braidwell LP(CIK: 0001920938)向美國 SEC 提交的 Form 13F 報告顯示,其追蹤之股票投資組合總市值達 US$27.0億,共持有 73 個公開申報部位。
觀察 Q3 2025 的資金脈絡,Braidwell LP 在獲利結算 19 檔個股的同時,將資本重新部署至 28 檔新選標的,展現主動管理機構的輪動節奏。
從部位權重觀察,前 5 大標的(包含 GH 1.25 02-15-31, CAI, NVCR 0 11-01-25)累計市值佔比達 36.8%,是驅動 Braidwell LP 該季度整體投資組合績效表現的核心支柱。
| # | 代號 | 標的名稱 | 資產子類別 | 佔比 | 佔比變動 | 持倉量變化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | GH 1.25 02-15-31債券 | Guardant Health Inc | 債券 | 8.49% | -3.42% | EXIT | |
| 2 | CAI | Caris Life Sciences Inc | 股票-其他 | 6.57% | +0.66% | — | |
| 3 | NVCR 0 11-01-25債券 | Novocure LTD | 債券 | 6.23% | — | +50.08% | |
| 4 | XENE | Xenon Pharmaceuticals Inc | 股票-其他 | 4.29% | -0.07% | — | |
| 5 | CGON | Cg Oncology Inc | 股票-其他 | 3.92% | -2.22% | EXIT | |
| 6 | NBIX | Neurocrine Biosciences Inc | 股票-醫療保健 | 3.67% | -0.77% | -24.14% | |
| 7 | RGEN 1 12-15-28債券 | Repligen CORP | 債券 | 3.02% | -2.68% | — | |
| 8 | KRYS | Krystal Biotech Inc | 股票-醫療保健 | 2.73% | +0.20% | -28.50% | |
| 9 | NUVL | Nuvalent Inc-a | 股票-其他 | 2.60% | -2.39% | EXIT | |
| 10 | NEO 0.25 01-15-28債券 | Neogenomics Inc | 債券 | 2.58% | -2.44% | -0.99% | |
| 11 | SLNOEUR | Soleno Therapeutics Inc | 股票-其他 | 2.57% | -1.07% | EXIT | |
| 12 | IRTC 1.5 09-01-29債券 | Irhythm Holdings Inc | 債券 | 2.53% | — | -11.43% | |
| 13 | EWTX | Edgewise Therapeutics Inc | 股票-其他 | 2.51% | +0.53% | — | |
| 14 | IRWD 1.5 06-15-26債券 | Ironwood Pharmaceuticals | 債券 | 2.16% | — | -11.43% | |
| 15 | INSP | Inspire Medical Systems Inc | 股票-醫療保健 | 1.95% | -0.05% | +69.17% | |
| 16 | GKOS | Glaukos CORP | 股票-醫療保健 | 1.89% | +0.32% | +29.29% | |
| 17 | DHR | Danaher CORP | 股票-醫療保健 | 1.82% | +0.18% | — | |
| 18 | LEGN | Legend Biotech Corp-adr | 股票-其他 | 1.77% | — | -28.16% | |
| 19 | ISRG | Intuitive Surgical Inc | 股票-醫療保健 | 1.73% | -0.16% | +45.34% | |
| 20 | APGE | Apogee Therapeutics Inc | 股票-其他 | 1.70% | -1.34% | EXIT | |
| 21 | ARGX | Argenx Se - Adr | 股票-醫療保健 | 1.67% | -1.46% | -60.88% | |
| 22 | TMO | Thermo Fisher Scientific Inc | 股票-醫療保健 | 1.64% | +0.14% | -15.75% | |
| 23 | ALGN | Align Technology Inc | 股票-醫療保健 | 1.52% | — | -17.52% | |
| 24 | ACAD | Acadia Pharmaceuticals Inc | 股票-醫療保健 | 1.51% | -0.30% | — | |
| 25 | HNGE | Hinge Health Inc-a | 股票-其他 | 1.33% | +2.21% | — | |
| 26 | SYRE | Spyre Therapeutics Inc | 股票-其他 | 1.28% | +1.32% | — | |
| 27 | TMDX | Transmedics Group Inc | 股票-醫療保健 | 1.17% | +0.41% | +37.72% | |
| 28 | IRTC | Irhythm Holdings Inc | 股票-醫療保健 | 1.15% | +0.48% | -24.73% | |
| 29 | PEN | Penumbra Inc | 股票-醫療保健 | 1.06% | -1.15% | EXIT | |
| 30 | KPTI 6 05-13-29 *債券 | Karyopharm Therapeutics | 債券 | 1.04% | — | — | |
| 31 | DYN | Dyne Therapeutics Inc | 股票-其他 | 1.02% | -0.26% | -16.58% | |
| 32 | CVS | Cvs Health CORP | 股票-醫療保健 | 0.98% | -0.70% | EXIT | |
| 33 | DNTH | Dianthus Therapeutics Inc | 股票-其他 | 0.97% | -0.38% | — | |
| 34 | CDNA | Caredx Inc | 股票-其他 | 0.94% | +0.03% | — | |
| 35 | BMRN | Biomarin Pharmaceutical Inc | 股票-醫療保健 | 0.85% | -0.94% | EXIT | |
| 36 | GMED | Globus Medical Inc - A | 股票-醫療保健 | 0.85% | — | +101.46% | |
| 37 | ORKA | Oruka Therapeutics Inc | 股票-其他 | 0.79% | +0.98% | NEW | |
| 38 | RGEN | Repligen CORP | 股票-醫療保健 | 0.78% | +0.70% | +35.35% | |
| 39 | KNSA | Kiniksa Pharmaceuticals International, plc | 股票-其他 | 0.74% | -0.01% | -41.67% | |
| 40 | THC | Tenet Healthcare CORP | 股票-醫療保健 | 0.73% | — | — | |
| 41 | MRVI | Maravai Lifesciences Hldgs-a | 股票-其他 | 0.71% | +1.04% | — | |
| 42 | EXK | Exact Sciences CORP | 股票-原物料 | 0.67% | — | — | |
| 43 | AKRO | Akero Therapeutics Inc | 股票-其他 | 0.67% | — | — | |
| 44 | ATEC | Alphatec Holdings Inc | 股票-其他 | 0.65% | +1.30% | -58.33% | |
| 45 | KIDS | Orthopediatrics CORP | 股票-其他 | 0.61% | +0.20% | — | |
| 46 | VKTX | Viking Therapeutics Inc | 股票-醫療保健 | 0.59% | — | -47.17% | |
| 47 | CSTL | Castle Biosciences Inc | 股票-其他 | 0.56% | — | — | |
| 48 | DRUG | Bright Minds Biosciences Inc | 股票-其他 | 0.55% | -0.05% | — | |
| 49 | RARE | Ultragenyx Pharmaceutical In | 股票-其他 | 0.53% | — | — | |
| 50 | HROW | Harrow Inc | 股票-其他 | 0.49% | -0.18% | EXIT |
| # | 代號 | 標的名稱 | 佔比變動 | 持倉量變化 | 異動類型 |
|---|---|---|---|---|---|
| 1 | NVCR 0 11-01-25債券 | Novocure LTD | +1.4% | +50.08% | 加碼 |
| 2 | XENE | Xenon Pharmaceuticals Inc | +1.1% | — | 加碼 |
| 3 | CGON | Cg Oncology Inc | +1.1% | — | 不變 |
| 4 | DNTH | Dianthus Therapeutics Inc | +0.7% | — | 加碼 |
| 5 | EWTX | Edgewise Therapeutics Inc | +0.6% | — | 加碼 |
| 6 | GH 1.25 02-15-31債券 | Guardant Health Inc | +0.5% | — | 不變 |
| 7 | NUVL | Nuvalent Inc-a | +0.5% | -13.85% | 加碼 |
| 8 | RGEN | Repligen CORP | +0.4% | +35.35% | 加碼 |
| 9 | CSTL | Castle Biosciences Inc | +0.3% | — | 加碼 |
| 10 | INSP | Inspire Medical Systems Inc | +0.3% | +69.17% | 加碼 |
| 11 | ORKA | Oruka Therapeutics Inc | +0.2% | -9.34% | 減碼 |
| 12 | ✓ | Zura Bio LTD | +0.2% | — | 不變 |
| 13 | ISRG | Intuitive Surgical Inc | +0.2% | +45.34% | 加碼 |
| 14 | KRYS | Krystal Biotech Inc | +0.2% | -28.50% | 加碼 |
| 15 | MRVI | Maravai Lifesciences Hldgs-a | +0.1% | — | 不變 |
| 16 | PEN | Penumbra Inc | 0% | +9.18% | 加碼 |
| 17 | SRPT | Sarepta Therapeutics Inc | -0.1% | — | 加碼 |
| 18 | LUNG | Pulmonx CORP | -0.1% | — | 不變 |
| 19 | REPL | Replimune Group Inc | -0.2% | +550.31% | 加碼 |
| 20 | SYRE | Spyre Therapeutics Inc | -0.2% | — | 不變 |
| 21 | XNCR | Xencor Inc | -0.2% | -24.73% | 減碼 |
| 22 | DXCM 0.25 11-15-25債券 | Dexcom Inc | -0.2% | -27.03% | 減碼 |
| 23 | GKOS | Glaukos CORP | -0.3% | +29.29% | 加碼 |
| 24 | DYN | Dyne Therapeutics Inc | -0.3% | -16.58% | 減碼 |
| 25 | APGE | Apogee Therapeutics Inc | -0.3% | -2.69% | 減碼 |
| 26 | KIDS | Orthopediatrics CORP | -0.4% | — | 不變 |
| 27 | RGEN 1 12-15-28債券 | Repligen CORP | -0.4% | — | 加碼 |
| 28 | HROW | Harrow Inc | -0.4% | -60.75% | 減碼 |
| 29 | DHR | Danaher CORP | -0.4% | — | 不變 |
| 30 | NEO 0.25 01-15-28債券 | Neogenomics Inc | -0.5% | -0.99% | 減碼 |
| 31 | DAWNGBX | Day One Biopharmaceuticals I | -0.5% | — | 減碼 |
| 32 | TMO | Thermo Fisher Scientific Inc | -0.6% | -15.75% | 減碼 |
| 33 | IRTC 1.5 09-01-29債券 | Irhythm Holdings Inc | -0.6% | -11.43% | 減碼 |
| 34 | VKTX | Viking Therapeutics Inc | -0.6% | -47.17% | 減碼 |
| 35 | IRWD 1.5 06-15-26債券 | Ironwood Pharmaceuticals | -0.7% | -11.43% | 減碼 |
| 36 | KNSA | Kiniksa Pharmaceuticals International, plc | -0.8% | -41.67% | 減碼 |
| 37 | TMDX | Transmedics Group Inc | -0.9% | +37.72% | 減碼 |
| 38 | ATEC | Alphatec Holdings Inc | -0.9% | -58.33% | 減碼 |
| 39 | IRTC | Irhythm Holdings Inc | -0.9% | -24.73% | 減碼 |
| 40 | ADPT | Adaptive Biotechnologies | -0.9% | -80.95% | 減碼 |
| 41 | NBIX | Neurocrine Biosciences Inc | -1% | -24.14% | 減碼 |
| 42 | IMCR 2.5 02-01-30債券 | Immunocore Holdings | -1.4% | -74.55% | 減碼 |
| 43 | ALGN | Align Technology Inc | -1.4% | -17.52% | 減碼 |
| 44 | ARGX | Argenx Se - Adr | -1.7% | -60.88% | 減碼 |
| 45 | LEGN | Legend Biotech Corp-adr | -1.8% | -28.16% | 減碼 |
| 46 | CAI | Caris Life Sciences Inc | — | NEW | 新建倉 |
| 47 | SLNOEUR | Soleno Therapeutics Inc | — | NEW | 新建倉 |
| 48 | BBIO 2.5 03-15-27債券 | Bridgebio Pharma Inc | — | EXIT | 清倉 |
| 49 | GH | Guardant Health Inc | — | EXIT | 清倉 |
| 50 | ACAD | Acadia Pharmaceuticals Inc | — | NEW | 新建倉 |
根據 SEC 官方 Form 13F 申報備案,Braidwell LP 在 Q3 2025 季度的美股持倉總市值約為 US$27.0億,共申報了 73 個公開持股部位。
在 Q3 2025 季度,Braidwell LP 按市值排列的前三大核心持股分別為:GH 1.25 02-15-31 (8.5%)、CAI (6.6%)、NVCR 0 11-01-25 (6.2%)。其中最大持股部位 GH 1.25 02-15-31 佔據整體投資組合約 8.5% 的權重。
精選 AlphaSMO 大戶持股與內部人交易深度分析,提升投資決策勝率
完整解讀 Form 13F 申報規範、1 億美元門檻與 45 天延遲申報機制,學會如何追蹤頂級對沖基金與機構法人持倉動向。
本季最大新建倉標的
CAI
市值: US$2.2億
本季最大獲利了結 / 清倉標的
BBIO 2.5 03-15-27
前期市值: US$7199.7萬
在 Q3 2025 季度中,Braidwell LP 共進行了 84 項持倉異動,包含新建倉 28 個部位、加碼 15 個部位、減碼 22 個部位以及清倉 19 個部位。 其中最大新建倉標的為 CAI。 本季清倉部位包含 BBIO 2.5 03-15-27。
本頁面所有持股數據均直接同步自美國證券交易委員會(SEC)EDGAR 官方系統之 13F-HR / 13F-HR/A 季度申報文件。AlphaSMO 透過機器解析 CUSIP 與個股對照,提供 100% 精準對齊的歷史時序數據集,並支援 Schema.org 結構化資料格式。
解析公司高管、董事與 10% 大股東之 Form 4 內部人交易申報,掌握高管自家股票買賣第一手訊號。
深入剖析 5% 股益申報門檻、13D 與 13G 之差異,以及最新 SEC 申報時程規範,洞察機構法人的激進投資動向。